Answers are grounded in this paper and cite their sources.
Background: Pulmonary arterial hypertension (PAH) requires a series of physical and supporting examinations to reach diagnosis, recognizing basic characteristics, cardiac structure, and hemodynamic is expected to speed up diagnosis and prevent delays in therapy. Methods: This study is a descriptive observational study with retrospective approach conducted in 45 patients with high probability of PAH through echocardiographic examination. Results: Most people with PAH are women (73.3%) aged 55-64 years (22.2%). The most common chief complaint was shortness of breath (66.7%) with WHO-FC II (47.6%). A total of 68.9% of PAH patients had congenital heart disease. On ECG, most patients did not experience arrythmia (71.7%), with 22.2% patients had right atrial enlargement, 48.9% patients had right axis deviation, 39.2% patients had right ventricular hypertrophy, and 44.4 % experienced right bundle branch block. Chest radiography found cardiomegaly in 64.4% patients. Echocardiographic examination found 45.2% right atrial dilatation and 45.2% right ventricular dilatation, with mean MPAP 52.2±39.4 mmHg, and mean SPAP 79.3±27.6 mmHg. The most frequently used type of therapy was PDE-5 inhibitor (59.5%). Conclusion: Patients enrolled were mostly adult women who had shortness of breath and a history of congenital heart disease. Sinus rhythm was common, but right heart enlargement and RBBB were still found in ECG. Cardiomegaly is also commonly found in PAH patients, and there is an increased mean of MPAP and SPAP on echocardiographic examination. The most commonly used therapy is PDE-5 inhibitor
No takes yet. Share an insight, caveat, or question.
Raihani et al. (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: